AR018622A1 - Compuestos (s)-(-)-1-[1-(4-sustituido o no sustituido, 2-metoxifenil)piperid-4-il]-n-(7-trifluorometil-2,3-dihidro-1,4-benzodioxin-2-il metil)metilamina,composiciones farmaceuticas que los comprenden, su uso para elaborar un medicamento y procedimiento para prepararlos - Google Patents
Compuestos (s)-(-)-1-[1-(4-sustituido o no sustituido, 2-metoxifenil)piperid-4-il]-n-(7-trifluorometil-2,3-dihidro-1,4-benzodioxin-2-il metil)metilamina,composiciones farmaceuticas que los comprenden, su uso para elaborar un medicamento y procedimiento para prepararlosInfo
- Publication number
- AR018622A1 AR018622A1 ARP990102619A ARP990102619A AR018622A1 AR 018622 A1 AR018622 A1 AR 018622A1 AR P990102619 A ARP990102619 A AR P990102619A AR P990102619 A ARP990102619 A AR P990102619A AR 018622 A1 AR018622 A1 AR 018622A1
- Authority
- AR
- Argentina
- Prior art keywords
- compound
- prepare
- formula
- compounds
- piperid
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/453—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a six-membered ring with oxygen as a ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Diabetes (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Obesity (AREA)
- Endocrinology (AREA)
- Hematology (AREA)
- Addiction (AREA)
- Child & Adolescent Psychology (AREA)
- Psychology (AREA)
- Hospice & Palliative Care (AREA)
- Urology & Nephrology (AREA)
- Reproductive Health (AREA)
- Epidemiology (AREA)
- Emergency Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9811879.7A GB9811879D0 (en) | 1998-06-03 | 1998-06-03 | Therapeutic agents |
Publications (1)
Publication Number | Publication Date |
---|---|
AR018622A1 true AR018622A1 (es) | 2001-11-28 |
Family
ID=10833098
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP990102619A AR018622A1 (es) | 1998-06-03 | 1999-06-03 | Compuestos (s)-(-)-1-[1-(4-sustituido o no sustituido, 2-metoxifenil)piperid-4-il]-n-(7-trifluorometil-2,3-dihidro-1,4-benzodioxin-2-il metil)metilamina,composiciones farmaceuticas que los comprenden, su uso para elaborar un medicamento y procedimiento para prepararlos |
Country Status (20)
Country | Link |
---|---|
EP (1) | EP1087964A1 (fr) |
JP (1) | JP2002517392A (fr) |
KR (1) | KR20010052526A (fr) |
CN (1) | CN1304408A (fr) |
AR (1) | AR018622A1 (fr) |
AU (1) | AU4369599A (fr) |
BG (1) | BG104988A (fr) |
BR (1) | BR9910927A (fr) |
CA (1) | CA2333756A1 (fr) |
CO (1) | CO5021190A1 (fr) |
GB (1) | GB9811879D0 (fr) |
HR (1) | HRP20010005A2 (fr) |
HU (1) | HUP0102233A2 (fr) |
ID (1) | ID27067A (fr) |
IL (1) | IL139552A0 (fr) |
NO (1) | NO20006041L (fr) |
PL (1) | PL344594A1 (fr) |
SK (1) | SK17602000A3 (fr) |
TR (1) | TR200003569T2 (fr) |
WO (1) | WO1999062902A1 (fr) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9915616D0 (en) * | 1999-07-05 | 1999-09-01 | Knoll Ag | Therapeutic agents |
GB0007376D0 (en) * | 2000-03-28 | 2000-05-17 | Knoll Ag | Therapeutic agents |
AU2001267421A1 (en) * | 2000-05-12 | 2001-11-20 | Solvay Pharmaceuticals B.V. | Use of compounds having combined dopamine d2, 5-ht1a and alpha adrenoreceptor agonistic action for treating cns disorders |
ATE255578T1 (de) * | 2000-05-12 | 2003-12-15 | Solvay Pharm Bv | Piperazin- und piperidinverbindungen |
GT200600078A (es) | 2005-02-17 | 2007-04-12 | Derivados de indol, benzotiofeno, benzofurano e indeno cicloalquil condensados |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2681325B1 (fr) * | 1991-09-16 | 1993-12-17 | Fabre Medicament Pierre | Derives de l'aminomethyl-4 piperidine, leur preparation et leur application en therapeutique. |
FR2701479B1 (fr) * | 1993-02-11 | 1995-05-12 | Pf Medicament | Nouveaux dérivés hétérocycliques de l'aminométhyl-4 pipéridine, leur préparation et leur application en thérapeutique. |
GB9318431D0 (en) * | 1993-09-06 | 1993-10-20 | Boots Co Plc | Therapeutic agents |
GB9514380D0 (en) * | 1995-07-13 | 1995-09-13 | Knoll Ag | Therapeutic agents |
-
1998
- 1998-06-03 GB GBGB9811879.7A patent/GB9811879D0/en not_active Ceased
-
1999
- 1999-05-26 IL IL13955299A patent/IL139552A0/xx unknown
- 1999-05-26 CN CN99806908A patent/CN1304408A/zh active Pending
- 1999-05-26 EP EP99926434A patent/EP1087964A1/fr not_active Ceased
- 1999-05-26 HU HU0102233A patent/HUP0102233A2/hu unknown
- 1999-05-26 ID IDW20002519A patent/ID27067A/id unknown
- 1999-05-26 WO PCT/EP1999/003648 patent/WO1999062902A1/fr not_active Application Discontinuation
- 1999-05-26 TR TR2000/03569T patent/TR200003569T2/xx unknown
- 1999-05-26 JP JP2000552113A patent/JP2002517392A/ja active Pending
- 1999-05-26 BR BR9910927-1A patent/BR9910927A/pt not_active IP Right Cessation
- 1999-05-26 PL PL99344594A patent/PL344594A1/xx not_active Application Discontinuation
- 1999-05-26 KR KR1020007013670A patent/KR20010052526A/ko not_active Application Discontinuation
- 1999-05-26 CA CA002333756A patent/CA2333756A1/fr not_active Abandoned
- 1999-05-26 SK SK1760-2000A patent/SK17602000A3/sk unknown
- 1999-05-26 AU AU43695/99A patent/AU4369599A/en not_active Abandoned
- 1999-06-03 AR ARP990102619A patent/AR018622A1/es not_active Application Discontinuation
- 1999-06-03 CO CO99035020A patent/CO5021190A1/es unknown
-
2000
- 2000-11-27 BG BG104988A patent/BG104988A/bg unknown
- 2000-11-29 NO NO20006041A patent/NO20006041L/no not_active Application Discontinuation
-
2001
- 2001-01-02 HR HR20010005A patent/HRP20010005A2/hr not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
AU4369599A (en) | 1999-12-20 |
JP2002517392A (ja) | 2002-06-18 |
NO20006041D0 (no) | 2000-11-29 |
CO5021190A1 (es) | 2001-03-27 |
SK17602000A3 (sk) | 2001-08-06 |
PL344594A1 (en) | 2001-11-05 |
BG104988A (bg) | 2001-11-30 |
HUP0102233A2 (hu) | 2002-05-29 |
WO1999062902A1 (fr) | 1999-12-09 |
IL139552A0 (en) | 2002-02-10 |
CA2333756A1 (fr) | 1999-12-09 |
NO20006041L (no) | 2000-11-29 |
BR9910927A (pt) | 2001-02-20 |
GB9811879D0 (en) | 1998-07-29 |
EP1087964A1 (fr) | 2001-04-04 |
HRP20010005A2 (en) | 2001-12-31 |
TR200003569T2 (tr) | 2001-04-20 |
KR20010052526A (ko) | 2001-06-25 |
CN1304408A (zh) | 2001-07-18 |
ID27067A (id) | 2001-02-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP2435432B3 (fr) | Agents induisant l'apoptose, dans le traitement du cancer et de maladies immunes et auto-immunes | |
DE60126344T2 (de) | Isoindolimid-verbindungen, zusammensetzungen und verwendungen | |
CN1972907A (zh) | 磺酰胺化合物 | |
CA2596355A1 (fr) | Inhibiteurs du facteur de necrose tumorale | |
JPS5995269A (ja) | 抗てんかん性医薬品 | |
FR2899586A1 (fr) | Dimeres de derives d'artemisinine, leur preparation et leur application en therapeutique | |
CN1094936C (zh) | 新黄酮化合物、制备它们的方法以及含有它们的药物组合物 | |
US20190084909A1 (en) | Fluorinated cbd compounds, compositions and uses thereof | |
CN103097355A (zh) | 用于治疗皮肤病的新的喹啉酯 | |
AR064134A1 (es) | Derivados de 2-aminoquinolina, un proceso para su preparacion, una composicion farmaceutica que los comprende y su uso en la fabricacion de un medicamento para el tratamiento de enfermedades mediadas por el antagonismo de los receptores 5-ht5a. | |
Varró et al. | The First Enantioselective Total Synthesis of (−)-trans-Dihydronarciclasine | |
Augstein et al. | Adrenergic neurone blocking agents derived from 1, 4-benzodioxan | |
Modi et al. | Potential anticancer agents. III. Schiff bases from benzaldehyde nitrogen mustards and aminophenylthiazoles | |
AR018622A1 (es) | Compuestos (s)-(-)-1-[1-(4-sustituido o no sustituido, 2-metoxifenil)piperid-4-il]-n-(7-trifluorometil-2,3-dihidro-1,4-benzodioxin-2-il metil)metilamina,composiciones farmaceuticas que los comprenden, su uso para elaborar un medicamento y procedimiento para prepararlos | |
WO2007144487A2 (fr) | Molecules duales contenant un derive peroxydique, leur synthese et leurs applications therapeutiques | |
DE4341402A1 (de) | N-substituierte Azabicycloheptan-Derivate, ihre Herstellung und Verwendung | |
JPS5980668A (ja) | N−アリル化オキサゾリジン−2−オンの光学活性な誘導体、該誘導体の製法及び該誘導体による薬剤 | |
JPH07505120A (ja) | チアフィゾベニンのカルバミン酸類縁化合物、医薬品用組成物、ならびにコリンエステラーゼ阻害方法 | |
US4260762A (en) | Octahydro-1H-pyrrolo[2,3-g]isoquinolines | |
US20040039023A1 (en) | Therapeutic agents | |
JPS60158190A (ja) | ヒダントイン誘導体およびその製法ならびにそれを含有する医薬 | |
Mansoor et al. | Silica-bonded N-propylpiperazine sodium n-propionate as an efficient recyclable catalyst for one-pot synthesis of 2-amino-4-aryl-4 H, 8 H-6-methyl-8-oxo-pyrano [3, 2-b] pyran derivatives | |
US4201783A (en) | Antidepressant substituted hexahydro benzopyrano [3,2-c] pyridines | |
US4442291A (en) | 1,2,3,4,4a,7-Hexahydro-6,8-dimethoxy-2-methyl isoquinoline | |
US4868315A (en) | Novel aryloxycycloalkanolaminoalkylene aryl ketones |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA | Abandonment or withdrawal |